Solara Active Pharma Sciences Ltd
NSE: SOLARA BSE: 541540
₹565.25
(1.46%)
Wed, 27 May 2026, 06:27 pm
Market Cap27.69B
PE Ratio0
Dividend0
Health Technology
Pharmaceuticals: Major
24.5KSolara Active Pharma Sciences Cashflow
| Particulars | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | 0 | -339.83M | -824.30M | -933.70M | -1.08B | -1.12B | -1.11B | -1.03B | -991.40M |
| Accumulated depreciation, total | — | -261.50M | -929.80M | -1.68B | -2.57B | -3.49B | -4.39B | -5.08B | -5.86B |
| Cash from operating activities | 0 | 273.51M | 900.90M | 1.71B | 818.80M | -3.05B | 761.50M | 94.30M | 1.00B |
| Funds from operations | -33.00K | 381.90M | 1.15B | 1.88B | 2.88B | 84.10M | 754.10M | -1.81B | 974.50M |
| Net income (cash flow) | -33.00K | 3.77M | 595.10M | 1.15B | 2.21B | -581.50M | -221.80M | -5.67B | 5.40M |
| Depreciation & amortization (cash flow) | — | 339.83M | 830.40M | 933.70M | 1.08B | 1.12B | 1.11B | 1.03B | 991.40M |
| Depreciation/depletion | — | 261.50M | 699.10M | 793.60M | 938.10M | 963.70M | 948.50M | 894.20M | 863.20M |
| Amortization | — | 103.12M | 131.30M | 140.10M | 141.70M | 152.70M | 156.90M | 132.40M | 128.20M |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | 0 | -16.20M | -353.30M | -207.70M | -417.60M | -121.30M | 96.90M | 2.05B | -22.30M |
| Changes in working capital | 33.00K | -108.39M | -252.90M | -164.50M | -2.06B | -3.14B | 7.40M | 1.91B | 30.20M |
| Cash from investing activities | 0 | -856.36M | -1.18B | -3.67B | -1.16B | -2.53B | -891.90M | -67.00M | -375.80M |
| Capital expenditures | 0 | -347.36M | -590.00M | -2.69B | -1.74B | -2.09B | -1.11B | -410.60M | -399.40M |
| Capital expenditures - fixed assets | 0 | -347.36M | -590.00M | -2.69B | -1.74B | -2.09B | -1.11B | -410.60M | -399.40M |
| Capital expenditures - other assets | 0 | 0 | — | 0 | 0 | — | — | — | — |
| Cash from financing activities | 100.00K | 897.77M | 541.40M | 1.76B | 1.76B | 4.07B | -253.10M | -30.20M | -673.80M |
| Free cash flow | 0 | -73.85M | 310.90M | -978.10M | -926.00M | -5.14B | -351.60M | -316.30M | 605.30M |